Somerset-based PharmScript, a pharmacy provider to long-term care and post-acute care facilities, announced on Monday the acquisition of UVANTA Kansas City, a long-term care pharmacy located in Kansas City, Kan.
Pharmscript said the acquisition builds on the company’s continued national expansion and furthers its service footprint in the Midwest by enabling service to health care facilities in Kansas and Missouri.
“We are thrilled to announce the next step in our strategic expansion plan,” said Michael Segal, chief executive officer of PharmScript. “This acquisition adds to PharmScript an established, experienced local operation in the heart of the Midwest. With this new team, PharmScript will continue to provide top-quality service to some of the leading long-term care facilities in Kansas and Missouri while bringing innovative technologies and capabilities to enhance this service,” Segal said.
As part of the acquisition, PharmScript said it would bring on board Kevin Kentfield, a local long-term care leader.
“I am incredibly excited to be a part of this PharmScript team, and I’m looking forward to contributing to the already impressive growth at PharmScript over the past several years,” said Kentfield. “I’m excited to kick-off the Midwest expansion and start pushing into new markets.”
Kentfield will join PharmScript as a vice president of customer experience and growth.
PharmScript currently services more than 700 long-term and post-acute care facilities across 20 states and the District of Columbia. The company provides quality assurance and innovative technology to help health care facilities administer medications safely and manage patients for optimal clinical outcomes while maintaining costs.
PharmScript serves health care providers across the South, Midwest, Mid-Atlantic and Northeast.